Skip to main content

Table 3 Cancer-Specific Survival according to treatment and risk groups to 7 years

From: Intensity-modulated radiotherapy versus radical prostatectomy in patients with localized prostate cancer: long-term follow-up

Cancer-specific survival

 

7 years (%)

95% CI

p value

All patients

RP

98.1

0.968-0.989

<0.001

IMRT

92.1

0.858-0.957

Low risk

RP

99.3

0.951-0.999

0.089

IMRT

97.4

0.825-0.996

Intermediate risk

RP

99.6

0.983-0.999

0.003

IMRT

94.1

0.823-0.981

High risk

RP

93.0

0.878-0.960

0.07

IMRT

85.4

0.704-0.932